{"id":"https://openalex.org/W4362546089","doi":"https://doi.org/10.1158/2326-6066.c.6548606.v1","title":"Data from The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity","display_name":"Data from The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362546089","doi":"https://doi.org/10.1158/2326-6066.c.6548606.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.6548606.v1","doi":"https://doi.org/10.1158/2326-6066.c.6548606.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6548606.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/2326-6066.c.6548606.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089451369","display_name":"Michael Hudecek","orcid":"https://orcid.org/0000-0002-2280-2202","observed_orcids":["https://orcid.org/0000-0002-2280-2202"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Hudecek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027027069","display_name":"Daniel Sommermeyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Sommermeyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046581575","display_name":"Paula L. Kosasih","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula L. Kosasih","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046247864","display_name":"Anne Silva-Benedict","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Silva-Benedict","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101957164","display_name":"Lingfeng Liu","orcid":"https://orcid.org/0000-0001-6182-9822","observed_orcids":["https://orcid.org/0000-0001-6182-9822"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lingfeng Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065812703","display_name":"Christoph M. Rader","orcid":"https://orcid.org/0000-0001-9955-3454","observed_orcids":["https://orcid.org/0000-0001-9955-3454"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christoph Rader","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010964073","display_name":"Michael C. Jensen","orcid":"https://orcid.org/0000-0001-7477-3063","observed_orcids":["https://orcid.org/0000-0001-7477-3063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael C. Jensen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5087281332","display_name":"Stanley R. Riddell","orcid":"https://orcid.org/0000-0002-4688-9920","observed_orcids":["https://orcid.org/0000-0002-4688-9920"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stanley R. Riddell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.9760000109672546},{"id":"https://openalex.org/keywords/fc-receptor-binding","display_name":"Fc receptor binding","score":0.9070000052452087},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.6710000038146973},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.8529999852180481},{"id":"https://openalex.org/keywords/ror1","display_name":"ROR1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7879999876022339},{"id":"https://openalex.org/keywords/t-cell-persistence","display_name":"T cell persistence","score":0.6430000066757202},{"id":"https://openalex.org/keywords/myeloid-cells","display_name":"myeloid cells","score":0.7630000114440918},{"id":"https://openalex.org/keywords/automotive-design","display_name":"automotive design","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7767817378044128},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6606850028038025},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5837797522544861},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.5585833191871643},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.519728422164917},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5020644664764404},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4151081442832947},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4081205725669861},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4063596725463867},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3980209231376648},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38773876428604126},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3870851397514343},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.348785936832428},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2917604446411133},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25640448927879333},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2563195824623108},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1135457456111908}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.6548606.v1","doi":"https://doi.org/10.1158/2326-6066.c.6548606.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6548606.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.6548606.v1","doi":"https://doi.org/10.1158/2326-6066.c.6548606.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.c.6548606.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2110820382","https://openalex.org/W2512142474","https://openalex.org/W3037312784","https://openalex.org/W2038410065","https://openalex.org/W4392346567","https://openalex.org/W2563718027","https://openalex.org/W4308375781","https://openalex.org/W4362546021","https://openalex.org/W1971654651","https://openalex.org/W2553096714"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"use":[2],"of":[3,27,45,49,57,111,176,192],"synthetic":[4],"chimeric":[5],"antigen":[6],"receptors":[7,146],"(CAR)":[8],"to":[9,13,21,37,82,98,144],"redirect":[10],"T":[11],"cells":[12,113],"recognize":[14],"tumor":[15,34,159],"provides":[16],"a":[17,65,115,153,165],"powerful":[18],"new":[19],"approach":[20],"cancer":[22],"immunotherapy;":[23],"however,":[24],"the":[25,43,55,85,89,92,126,172,177,190],"attributes":[26],"CARs":[28,150,193],"that":[29,62,104,129,139,141,171,181],"ensure":[30],"optimal":[31,195],"in":[32,73,79,105,125,151,189,196],"vivo":[33,80,106,197],"recognition":[35,160],"remain":[36],"be":[38,119,187],"defined.":[39],"Here,":[40],"we":[41],"analyze":[42],"influence":[44],"length":[46,173],"and":[47,91,108,174],"composition":[48,175],"IgG-derived":[50],"extracellular":[51,178],"spacer":[52,67,90,117,155,179],"domains":[53],"on":[54],"function":[56,185],"CARs.":[58],"Our":[59,136],"studies":[60,137],"demonstrate":[61,103,138,170],"CD19-CARs":[63],"with":[64,114],"long":[66,116,154],"from":[68],"IgG4":[69],"hinge-CH2-CH3":[70],"are":[71,130,147],"functional":[72],"vitro":[74],"but":[75],"lack":[76],"antitumor":[77,109],"activity":[78],"due":[81],"interaction":[83],"between":[84],"Fc":[86,93,133,145],"domain":[87,128,180],"within":[88],"receptor\u2013bearing":[94],"myeloid":[95],"cells,":[96],"leading":[97],"activation-induced":[99],"T-cell":[100],"death.":[101],"We":[102],"persistence":[107],"effects":[110],"CAR-T":[112],"can":[118,186],"restored":[120],"by":[121],"modifying":[122],"distinct":[123],"regions":[124],"CH2":[127],"essential":[131],"for":[132,149,158,164,194],"receptor":[134],"binding.":[135],"modifications":[140],"abrogate":[142],"binding":[143],"crucial":[148],"which":[152],"is":[156],"obligatory":[157],"as":[161],"shown":[162],"here":[163],"ROR1-specific":[166],"CAR.":[167],"These":[168],"results":[169],"lacks":[182],"intrinsic":[183],"signaling":[184],"decisive":[188],"design":[191],"activity.":[198],"Cancer":[199],"Immunol":[200],"Res;":[201],"3(2);":[202],"125\u201335.":[203],"\u00a92014":[204],"AACR.":[205]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-04-06T00:00:00"}